TABLE 2. Percentage of women and men aged 15–44 years receiving contraceptive, infertility, and STD/HIV testing and prevention services, by race/ethnicity — National Survey of Family Growth, 2011–2013 and National Health Interview Survey, 2013.
| Type of service | Non-Hispanic white |
Non-Hispanic black |
Hispanic |
Non-Hispanic other or multiple races |
|---|---|---|---|---|
| % (95% CI) | % (95% CI) | % (95% CI) | % (95% CI) | |
|
Received contraceptive services in past yr* (NSFG)
| ||||
|
Women
| ||||
| Among women aged 15–44 yrs at risk for unintended pregnancy† |
47.9 (44.3–51.6) |
44.0 (38.8–49.1) |
43.8 (38.6–49.0) |
47.0 (40.0–54.0) |
| Among women using sterilization, IUD, or implant |
28.7 (24.2–33.3) |
25.8 (17.7–34.0) |
28.1 (21.4–34.7) |
—§ |
| Among women using a moderately effective method¶ |
98.1 (96.7–99.5) |
94.4 (87.4–100) |
96.3 (93.3–99.3) |
— |
| Among women using a less effective method** |
32.2 (24.7–39.7) |
34.8 (27.1–42.4) |
39.2 (31.3–47.1) |
— |
| Among women using no method |
19.6 (10.9–28.3) |
27.9 (18.5–37.3) |
23.2 (13.0–33.5) |
— |
|
Men
| ||||
| Among men aged 15–44 yrs who had vaginal intercourse in the past yr |
4.3 (2.6–6.0) |
5.3 (3.4–7.2) |
4.6 (3.0–6.2) |
4.7 (1.7–7.8) |
|
Ever received medical services for achieving pregnancy†† (NSFG)
| ||||
|
Advice, no additional medical services
| ||||
| Among women aged 15–44 yrs |
1.7 (1.0–2.5) |
0.9 (0.4–1.5) |
1.4 (0.4–2.5) |
0.8 (0.0–1.6) |
|
Medical services beyond advice
| ||||
| Among women aged 15–44 yrs |
7.4 (5.7–9.1) |
3.1 (1.3–4.8) |
2.8 (1.7–3.8) |
7.4 (2.7–12.2) |
|
Received STD screening services in the past yr (NSFG)
| ||||
|
Women
| ||||
|
Chlamydia screening
| ||||
| Among women aged 15–24 yrs who had oral, anal, or vaginal sex with male partner in the past yr |
31.6 (25.3–37.9) |
60.5 (50.2–70.8) |
36.7 (29.3–44.1) |
— |
| Among women aged 15–44 yrs who had oral, anal, or vaginal sex with a male partner in the past yr and were not in a mutually monogamous relationship§§ |
42.2 (34.2–50.3) |
51.6 (42.0–61.2) |
52.1 (44.2–60.0) |
— |
| Among women aged 15–44 yrs who were pregnant in the past yr |
38.5 (30.1–46.9) |
83.1 (75.3–90.9) |
44.0 (32.2–55.8) |
— |
|
Screening for any STD other than chlamydia
| ||||
| Among women aged 15–44 yrs who had oral, anal, or vaginal sex with a male partner in the past yr and were not in a mutually monogamous relationship§§ |
44.0 (35.6–52.5) |
61.1 (53.7–68.4) |
55.5 (46.7–64.3) |
— |
|
Men
| ||||
|
Screening for any STD
| ||||
| Among men aged 15–44 yrs who had oral, anal, or vaginal sex with a female partner in the past yr were not in a mutually monogamous relationship§§ |
26.5 (20.9–32.2) |
44.8 (37.6–51.9) |
37.0 (28.2–45.7) |
— |
|
STD services ever received (NSFG and NHIS)
| ||||
|
Women
| ||||
|
Ever tested for HIV
| ||||
| Among women aged 15–44 yrs (NSFG)¶¶ |
57.5 (53.8–61.2) |
80.5 (76.4–84.5) |
66.0 (62.1–69.9) |
55.2 (49.8–60.6) |
|
Ever received the hepatitis B vaccine
| ||||
| Among women aged 18–44 yrs (NHIS) |
49.7 (47.6–51.9) |
43.4 (40.0–46.9) |
39.1 (35.9–42.5) |
49.4 (44.8–54.0) |
|
Ever received at least three doses of the hepatitis B vaccine
| ||||
| Among women aged 18–44 yrs (NHIS) |
43.4 (41.3–45.6) |
36.6 (33.2–40.2) |
29.5 (26.4–32.7) |
42.9 (38.3–47.7) |
|
Ever received the HPV vaccine
| ||||
| Among women aged 18–26 yrs (NHIS)*** |
41.2 (37.2–45.3) |
30.9 (25.4–36.9) |
30.8 (25.5–36.8) |
29.0 (20.3–39.4) |
|
Ever received at least three doses of the HPV vaccine
| ||||
| Among women aged 18–26 yrs (NHIS)*** |
30.5 (26.9–34.4) |
14.5 (10.4–19.7) |
17.4 (13.2–22.5) |
20.0 (13.7–28.3) |
|
Men
| ||||
|
Ever tested for HIV
| ||||
| Among men aged 15–44 yrs (NSFG)¶¶ | 42.9 (39.2–46.6) | 68.6 (64.1–73.1) | 44.2 (38.6–49.8) | 49.0 (41.6–56.4) |
Abbreviations: CI = confidence interval; HIV = human immunodeficiency virus; HPV = human papilloma virus; IUD = intrauterine device; NHIS = National Health Interview Survey; NSFG = National Survey of Family Growth; STD = sexually transmitted disease.
* For women, contraceptive services include receiving a birth control method or a prescription, receiving a checkup for birth control, receiving counseling about birth control, receiving a sterilizing operation, receiving counseling about a sterilizing operation, receiving emergency contraception, and receiving counseling about emergency contraception. For men, contraceptive services include receiving information or advice about using condoms, information or advice about female methods of birth control, and information or advice about getting a vasectomy.
† Women were considered at risk for unintended pregnancy if they had ever had vaginal intercourse; were neither pregnant, seeking pregnancy, nor postpartum; and neither they nor their partner were noncontraceptively sterile. Postpartum women were identified to have completed a recent pregnancy ≤2.5 months before interview according to the coding specifications (https://www.cdc.gov/nchs/data/nsfg/nsfg_2011-2013_app3a_femresprecodespecs_v2.pdf).
§ Does not meet reliability standards.
¶ Includes injectable, patch, ring, pill, and diaphragm.
** Includes condoms, withdrawal, morning-after pill, foam, sponge, suppository or insert, jelly or cream, periodic abstinence, and other (unspecified) methods.
†† Medical services to help women achieve pregnancy include infertility testing (for herself or her male partner), ovulation stimulation, surgery to correct blocked tubes, artificial insemination, and other types of medical help.
§§ Had more than one opposite sex partner in the past year, or had an opposite sex partner with other partners in the past year.
¶¶ Includes testing outside of a blood donation only.
*** Includes women aged 18–26 years only because the HPV vaccine is not recommended for women aged >26 years.